Mangalachulli Pottammal Ranjith1, Rajendran DivyaRaj2, Dolly Mathew3, Biju George4, Mangalath Narayanan Krishnan3. 1. Department of Cardiology , Kannur Medical College , Anjarakandy, Kerala , India. 2. Department of Neurology, SN Mission Hospital , Varkala, Kerala , India. 3. Department of Cardiology , Government Medical College , Kozhikode, Kerala , India. 4. Department of Community Medicine , Government Medical College , Kozhikode, Kerala , India.
Abstract
OBJECTIVE: High levels of mean platelet volume (MPV) may be associated with adverse outcomes in patients with myocardial infarction (MI). We examined the association between MPV and the risk of death and adverse cardiovascular outcomes in patients with MI. METHODS: We studied consecutive patients with MI admitted to a tertiary-care hospital during a period of 1 year. MPV was measured at admission and at third month. Patients were followed up for 1-year primary composite outcome of cardiovascular death, stroke, fatal or non-fatal MI and cardiac failure. Patients were classified according to tertile of baseline MPV. RESULTS: A total of 1206 patients with MI, including 934 men (77.4%) and 272 women (22.6%) were studied. The mean age of the study population was 56 years. At 1-year follow-up, 292 (28.57%) primary outcome occurred: cardiovascular mortality 78 (7.6%), fatal or non-fatal MI 153 (15.0%), stroke 30 (2.9%) and cardiac failure 128 (12.52%). Patients with the highest tertile MPV had higher primary outcome as compared with those with MPV in the lowest tertile (adjusted OR=2.31; 95% CI 1.60 to 3.35; p<0.001). Total mortality was also more in high-MPV group (adjusted OR 2.62; 95% CI 1.47 to 4.70; p<0.001). There were no significant changes in mean MPV values at admission from those at third month interval (9.15, (SD 0.99) vs 9.19 (SD 0.94); p=0.2). CONCLUSIONS: Elevated MPV was associated with worse outcome in patients with acute MI. Elevated MPV in these patients may be due to inherently large platelets. TRIAL REGISTRATION NUMBER: http://ctri.nic.in/Clinicaltrials/rmaindet.php?trialid=5485&EncHid=98036.61144&modid=1&compid=19; CTRI/2012/12/003222.
OBJECTIVE: High levels of mean platelet volume (MPV) may be associated with adverse outcomes in patients with myocardial infarction (MI). We examined the association between MPV and the risk of death and adverse cardiovascular outcomes in patients with MI. METHODS: We studied consecutive patients with MI admitted to a tertiary-care hospital during a period of 1 year. MPV was measured at admission and at third month. Patients were followed up for 1-year primary composite outcome of cardiovascular death, stroke, fatal or non-fatal MI and cardiac failure. Patients were classified according to tertile of baseline MPV. RESULTS: A total of 1206 patients with MI, including 934 men (77.4%) and 272 women (22.6%) were studied. The mean age of the study population was 56 years. At 1-year follow-up, 292 (28.57%) primary outcome occurred: cardiovascular mortality 78 (7.6%), fatal or non-fatal MI 153 (15.0%), stroke 30 (2.9%) and cardiac failure 128 (12.52%). Patients with the highest tertile MPV had higher primary outcome as compared with those with MPV in the lowest tertile (adjusted OR=2.31; 95% CI 1.60 to 3.35; p<0.001). Total mortality was also more in high-MPV group (adjusted OR 2.62; 95% CI 1.47 to 4.70; p<0.001). There were no significant changes in mean MPV values at admission from those at third month interval (9.15, (SD 0.99) vs 9.19 (SD 0.94); p=0.2). CONCLUSIONS: Elevated MPV was associated with worse outcome in patients with acute MI. Elevated MPV in these patients may be due to inherently large platelets. TRIAL REGISTRATION NUMBER: http://ctri.nic.in/Clinicaltrials/rmaindet.php?trialid=5485&EncHid=98036.61144&modid=1&compid=19; CTRI/2012/12/003222.
Authors: Tomasz Rechciński; Aleksandra Jasińska; Jakub Foryś; Maria Krzemińska-Pakuła; Karina Wierzbowska-Drabik; Michał Plewka; Jan Zbigniew Peruga; Jarosław Damian Kasprzak Journal: Cardiol J Date: 2013 Impact factor: 2.737
Authors: C M Gibson; S A Murphy; M J Rizzo; K A Ryan; S J Marble; C H McCabe; C P Cannon; F Van de Werf; E Braunwald Journal: Circulation Date: 1999-04-20 Impact factor: 29.690
Authors: P M Ridker; N Rifai; M A Pfeffer; F M Sacks; L A Moye; S Goldman; G C Flaker; E Braunwald Journal: Circulation Date: 1998-09-01 Impact factor: 29.690
Authors: Mücahid Yılmaz; Mustafa Necati Dağlı; Ökkeş Uku; Mehmet Nail Bilen; Hasan Korkmaz; Kenan Erdem; Ertuğrul Kurtoğlu Journal: Vasc Health Risk Manag Date: 2017-07-07